The effectiveness of measures to change the indoor environment in the treatment of allergic rhinitis and asthma: ARIA update (in collaboration with GA(2)LEN).
about
Interventions to reduce individual exposure of elderly individuals and children to haze: a reviewMite-Allergic Rhinitis: How to Evaluate Clinical Efficacy in Allergen-Specific Immunotherapy Trials?The relationship of housing and population health: a 30-year retrospective analysisEnvironmental triggers and avoidance in the management of asthmaTypes of sensitization to aeroallergens: definitions, prevalences and impact on the diagnosis and treatment of allergic respiratory diseaseAllergen Avoidance in Allergic AsthmaClinical practice: Breastfeeding and the prevention of allergy.Effects of high and low temperatures on development time and mortality of house dust mite eggs.Clinical utility and patient adherence with ebastine for allergic rhinitis.Clinical practice guideline: Allergic rhinitis.Optimal management of severe/refractory asthma.Trigger recognition and management in poorly controlled asthmaticsAeroallergens in West Crete, Greece: A five year (2010-2014) aerobiological study.Allergic Rhinitis and Its Impact on Asthma in Asia Pacific and the ARIA Update 2008Allergic rhinitis and its impact on otorhinolaryngology.Common household activities are associated with elevated particulate matter concentrations in bedrooms of inner-city Baltimore pre-school childrenNovel therapeutic interventions for allergic rhinitis.Allergic rhinoconjunctivitis in childrenPerceived triggers of asthma: key to symptom perception and management.Montelukast in the management of allergic rhinitisEncasing bedding in covers made of microfine fibers reduces exposure to house mite allergens and improves disease management in adult atopic asthmatics.Allergic rhinitis in women.Investigational drugs for allergic rhinitis.Emerging drugs for perennial allergic rhinitis.Paediatric rhinitis: position paper of the European Academy of Allergy and Clinical Immunology.Investigational drugs for the treatment of allergic rhinitis.Environmental controls and avoidance measures.Emerging drugs for the treatment of perennial allergic rhinitis.SQ house dust mite (HDM) SLIT-tablet provides clinical improvement in HDM-induced allergic rhinitis.Relevance of a 5-grass sublingual tablet for immunotherapy of patients with grass pollen allergy in North America.Efficacy and safety of SQ house dust mite (HDM) SLIT-tablet treatment of HDM allergic asthma.Outpatient management of asthma in children.Specific immunotherapy for rhinitis and asthma with a subcutaneous hypoallergenic high-dose house dust mite extract: results of a 9-month therapy.Occupational rhinitis in bell pepper greenhouse workers: determinants of leaving work and the effects of subsequent allergen avoidance on health-related quality of lifeResponse
P2860
Q26767384-0DC33C32-9FC8-49D5-823B-20319BEA2A03Q28082353-46FF70AB-8013-4DBD-9EE1-B55CCC133FA9Q28388614-26383CD3-C98D-4178-B64A-DC7F26F5AD34Q29247976-0D1B2F90-5D17-4614-84AC-E0D0D9CCCED0Q33592972-F3C5361B-4BDF-45E2-A09E-5F068DC35F50Q33653658-7784D822-692E-4C9A-820C-F602A154839BQ33931478-8C48515F-7ACB-4345-8321-9A6867D200ACQ34200005-FEF0CE85-9FD7-4ACE-96E3-B116E3E62CC5Q34413618-3399E880-26A6-452B-BFE3-0C7638D8C483Q34460983-AF0F1C24-E6E9-406B-89D2-5DBC1D2D0EC6Q35193179-56546650-8581-41CF-85FB-C17FD9C8A083Q35601499-7D6E999E-397D-4F8E-A0C7-6CDC7BB24A06Q35955344-A9CB7F92-7933-4D82-8D86-5510139AA3A0Q36371027-B7C9A5D4-F026-4333-A2BD-BF4DF000D0C2Q36469365-64E40B0B-B20E-448C-9C3D-CE4470B160F8Q36537001-666E5119-F994-47FF-A89A-C1E4FEC4B426Q36654345-3095314D-683E-4F2B-9C84-E6EBADFA95BAQ36997007-61BE8CE6-19F1-46CD-BDD2-7E25D7633E36Q37107695-1F164953-CA4D-4A91-B10F-9FC3B58057E7Q37116842-56907CF4-319C-4CC2-AE62-5EA44E34121AQ37313682-BE791F9A-A774-4270-84CD-5FD36E5EE95FQ37608446-21F76D67-B320-4AFD-A3A0-8B99FD42C3E4Q37650382-9CA94630-A650-4FDD-B2E3-807B7F6FC48DQ38062942-2F364660-F71C-4288-8DEB-8156E5B27AEEQ38129435-89612880-864C-4B80-8CAB-8609938FDC27Q38202695-A6D0D42E-44AF-4A57-BDA6-2D1F722B6D9CQ38245580-78E2C2B3-3D4A-48D7-B46A-CD2235DDA100Q38687640-19CD6DBA-558B-41B0-80E4-1AF76B681CACQ38703818-625F93F9-D9B8-4472-A3B8-DDD26DF4C7ABQ38712422-0C2ED5C7-00DA-41EC-863D-1E920250DFDDQ38870647-65DDF52F-C8E0-4BE9-89D8-90A4561D4279Q39936622-A4F11DB1-F5F6-4EF1-8707-271474986578Q53608022-36B333B3-B939-4DC5-88A4-9445D69196EEQ57121672-D13B2F54-3A81-4518-AA1A-68AB811C4FAAQ57137713-781D4711-FBB5-43DF-92F8-86B5D0B2DBA6
P2860
The effectiveness of measures to change the indoor environment in the treatment of allergic rhinitis and asthma: ARIA update (in collaboration with GA(2)LEN).
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
The effectiveness of measures ...... collaboration with GA(2)LEN).
@ast
The effectiveness of measures ...... collaboration with GA(2)LEN).
@en
type
label
The effectiveness of measures ...... collaboration with GA(2)LEN).
@ast
The effectiveness of measures ...... collaboration with GA(2)LEN).
@en
prefLabel
The effectiveness of measures ...... collaboration with GA(2)LEN).
@ast
The effectiveness of measures ...... collaboration with GA(2)LEN).
@en
P2860
P1433
P1476
The effectiveness of measures ...... n collaboration with GA(2)LEN)
@en
P2093
P2860
P304
P356
10.1111/J.1398-9995.2005.00934.X
P577
2005-09-01T00:00:00Z